{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:03:13Z","timestamp":1794974593699,"version":"4.9.1"},"reference-count":53,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2024,5,15]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Epidemiological studies have reported an association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease (MASLD). However, the magnitude of the risk and whether this risk changes with the severity of MASLD remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between primary hypothyroidism and the risk of MASLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Scopus and Web of Science from database inception to 31 January 2024, using predefined keywords to identify observational studies in which MASLD was diagnosed by liver biopsy, imaging or International Classification of Diseases codes. A meta-analysis was performed using random-effects modelling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 24 cross-sectional and 4 longitudinal studies with aggregate data on ~76.5\u2009million individuals. Primary hypothyroidism (defined as levothyroxine replacement treatment, subclinical hypothyroidism or overt hypothyroidism) was associated with an increased risk of prevalent MASLD (n=24 studies; random-effects OR 1.43, 95% CI 1.23 to 1.66; I\n                      <jats:sup>2<\/jats:sup>\n                      =89%). Hypothyroidism was also associated with a substantially higher risk of metabolic dysfunction-associated steatohepatitis or advanced fibrosis (n=5 studies; random-effects OR 2.84, 95% CI 2.07 to 3.90; I\n                      <jats:sup>2<\/jats:sup>\n                      =0%). Meta-analysis of data from four longitudinal studies showed that there was a marginally non-significant association between hypothyroidism and risk of developing MASLD over a median 4.5-year follow-up (random-effects HR 1.39, 95% CI 0.98 to 1.97; I\n                      <jats:sup>2<\/jats:sup>\n                      =85%). Sensitivity analyses did not modify these findings. The funnel plot did not reveal any significant publication bias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This large and updated meta-analysis provides evidence that primary hypothyroidism is significantly associated with both an increased presence of and histological severity of MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2024-332491","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:20:53Z","timestamp":1716470453000},"page":"1554-1561","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":50,"title":["Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis"],"prefix":"10.1136","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-6329","authenticated-orcid":false,"given":"Alessandro","family":"Mantovani","sequence":"first","affiliation":[{"name":"Endocrinology and Metabolism, University of Verona Faculty of Medicine and Surgery, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3420-4998","authenticated-orcid":false,"given":"Alessandro","family":"Csermely","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, University of Verona Faculty of Medicine and Surgery, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Bilson","sequence":"additional","affiliation":[{"name":"Southampton General Hospital, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Borella","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, University of Verona Faculty of Medicine and Surgery, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scoccia","family":"Enrico","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, University of Verona Faculty of Medicine and Surgery, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pecoraro","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, University of Verona Faculty of Medicine and Surgery, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emigela","family":"Shtembari","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, University of Verona Faculty of Medicine and Surgery, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Morandin","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism, University of Verona Faculty of Medicine and Surgery, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A","family":"Polyzos","sequence":"additional","affiliation":[{"name":"First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki Faculty of Health Sciences, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-0345","authenticated-orcid":false,"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Precision Medicine Lab, Biological Resource Center, IRCCS C\u00e0 Granda Ospedale Maggiore Policlinico, milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-2579","authenticated-orcid":false,"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medizinische Universitat Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-7753","authenticated-orcid":false,"given":"Christopher D","family":"Byrne","sequence":"additional","affiliation":[{"name":"Southampton General Hospital, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-3900","authenticated-orcid":false,"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[{"name":"Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella (VR), Italy"},{"name":"Department of Medicine, University of Verona Faculty of Medicine and Surgery, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"2025120600394040000_73.9.1554.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003"},{"key":"2025120600394040000_73.9.1554.2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330595"},{"key":"2025120600394040000_73.9.1554.3","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000004"},{"key":"2025120600394040000_73.9.1554.4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330110"},{"key":"2025120600394040000_73.9.1554.5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00317-X"},{"key":"2025120600394040000_73.9.1554.6","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00501-9"},{"key":"2025120600394040000_73.9.1554.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2314365"},{"key":"2025120600394040000_73.9.1554.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.12.014"},{"key":"2025120600394040000_73.9.1554.9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330596"},{"key":"2025120600394040000_73.9.1554.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"},{"key":"2025120600394040000_73.9.1554.11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0257"},{"key":"2025120600394040000_73.9.1554.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025120600394040000_73.9.1554.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2025120600394040000_73.9.1554.14","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"2025120600394040000_73.9.1554.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2025120600394040000_73.9.1554.16","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200310000-00014"},{"key":"2025120600394040000_73.9.1554.17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0279"},{"key":"2025120600394040000_73.9.1554.18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-2006-2"},{"key":"2025120600394040000_73.9.1554.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.027"},{"key":"2025120600394040000_73.9.1554.20","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-012-0008-8"},{"key":"2025120600394040000_73.9.1554.21","first-page":"584","article-title":"Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors","volume":"16","author":"Eshraghian","year":"2013","journal-title":"Arch Iran Med"},{"key":"2025120600394040000_73.9.1554.22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0150"},{"key":"2025120600394040000_73.9.1554.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-015-0030-5","article-title":"Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years","volume":"15","author":"Ludwig","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"2025120600394040000_73.9.1554.24","first-page":"1","article-title":"Prevalence of elevated TSH and its association with Dyslipidemia and NAFLD among Filipino adult executive check-up patients in a tertiary hospital","volume":"55","author":"Lingad-Sayas","year":"2017","journal-title":"Philipp J Intern Med"},{"key":"2025120600394040000_73.9.1554.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.08.014"},{"key":"2025120600394040000_73.9.1554.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.11.024"},{"key":"2025120600394040000_73.9.1554.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2019.03.025"},{"key":"2025120600394040000_73.9.1554.28","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12124"},{"key":"2025120600394040000_73.9.1554.29","doi-asserted-by":"publisher","DOI":"10.1177\/0049475520945058"},{"key":"2025120600394040000_73.9.1554.30","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v14.i3.551"},{"key":"2025120600394040000_73.9.1554.31","doi-asserted-by":"crossref","DOI":"10.4103\/abr.abr_15_21","article-title":"Association of Subclinical hypothyroidism with Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A cross-sectional study","volume":"11","author":"Sheikhi","year":"2022","journal-title":"Adv Biomed Res"},{"key":"2025120600394040000_73.9.1554.32","article-title":"Low-normal thyroid function is not associated with either non-alcoholic fatty liver disease or with metabolic dysfunction-associated fatty liver disease","volume":"13","author":"Zuarth-V\u00e1zquez","year":"2023","journal-title":"Life (Basel)"},{"key":"2025120600394040000_73.9.1554.33","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16163"},{"key":"2025120600394040000_73.9.1554.34","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad016"},{"key":"2025120600394040000_73.9.1554.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-022-02612-3","article-title":"Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease","volume":"23","author":"Fan","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"2025120600394040000_73.9.1554.36","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/381014","article-title":"Hepatic steatosis and thyroid function tests in overweight and obese children","volume":"2013","author":"Pacifico","year":"2013","journal-title":"Int J Endocrinol"},{"key":"2025120600394040000_73.9.1554.37","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12110"},{"key":"2025120600394040000_73.9.1554.38","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02041-3"},{"key":"2025120600394040000_73.9.1554.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.05.025"},{"key":"2025120600394040000_73.9.1554.40","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.21.4.372"},{"key":"2025120600394040000_73.9.1554.41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1300"},{"key":"2025120600394040000_73.9.1554.42","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13038","article-title":"Low thyroid function is associated with metabolic dysfunction-associated Steatotic liver disease","volume":"8","author":"Wang","year":"2024","journal-title":"JGH Open"},{"key":"2025120600394040000_73.9.1554.43","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15847"},{"key":"2025120600394040000_73.9.1554.44","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15723"},{"key":"2025120600394040000_73.9.1554.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.08.012"},{"key":"2025120600394040000_73.9.1554.46","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025738","article-title":"The relationship between non-alcoholic fatty liver disease and hypothyroidism: A systematic review and meta-analysis","volume":"100","author":"Zeng","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"2025120600394040000_73.9.1554.47","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5753039","article-title":"Benefits of Levothyroxine replacement therapy on Nonalcoholic fatty liver disease in Subclinical hypothyroidism patients","volume":"2017","author":"Liu","year":"2017","journal-title":"Int J Endocrinol"},{"key":"2025120600394040000_73.9.1554.48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00475"},{"key":"2025120600394040000_73.9.1554.49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.23736\/S0391-1977.17.02617-7","article-title":"Thyroid dysfunction and non-alcoholic fatty liver disease","volume":"43","author":"Efstathiadou","year":"2018","journal-title":"Minerva Endocrinol"},{"key":"2025120600394040000_73.9.1554.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.06.037"},{"key":"2025120600394040000_73.9.1554.51","unstructured":"FDA APPROVES first treatment for patients with liver Scarring due to fatty liver disease. n.d. Available: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease"},{"key":"2025120600394040000_73.9.1554.52","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32728"},{"key":"2025120600394040000_73.9.1554.53","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2024-332491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:39:50Z","timestamp":1765010390000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2024-332491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,8,8]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/gutjnl-2024-332491"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2024-332491","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]}}}